Patents by Inventor Jacob M. Ludwig
Jacob M. Ludwig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230330416Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system is included having at least one electric field generating circuit configured to generate one or more electric fields; control circuitry in communication with the electric field generating circuit, the control circuitry configured to control delivery of the one or more electric fields from the at least one electric field generating circuit; and two or more electrodes to deliver the electric fields to the site of a cancerous tumor within a patient. At least one electrode can be configured to be implanted. At least one electrode can be configured to be external. The control circuitry can cause the electric field generating circuit to generate one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz.Type: ApplicationFiled: March 20, 2023Publication date: October 19, 2023Inventors: Brian L. Schmidt, Devon N. Arnholt, Benjamin Keith Stein, Keith R. Maile, William J. Linder, Ron A. Balczewski, Jacob M. Ludwig, Aleksandra Kharam
-
Patent number: 11607542Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system is included having at least one electric field generating circuit configured to generate one or more electric fields; control circuitry in communication with the electric field generating circuit, the control circuitry configured to control delivery of the one or more electric fields from the at least one electric field generating circuit; and two or more electrodes to deliver the electric fields to the site of a cancerous tumor within a patient. At least one electrode can be configured to be implanted. At least one electrode can be configured to be external. The control circuitry can cause the electric field generating circuit to generate one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz.Type: GrantFiled: April 22, 2020Date of Patent: March 21, 2023Assignee: Boston Scientific Scimed, Inc.Inventors: Brian L. Schmidt, Devon N. Arnholt, Benjamin Keith Stein, Keith R. Maile, William J. Linder, Ron A. Balczewski, Jacob M. Ludwig, Aleksandra Kharam
-
Patent number: 11590353Abstract: Implantable medical devices (IMD), such as but not limited to leadless cardiac pacemakers (LCP), subcutaneous implantable cardioverter defibrillators (SICD), transvenous implantable cardioverter defibrillators, neuro-stimulators (NS), implantable monitors (IM), may be configured to communicate with each other. In some cases, a first IMD may transmit instructions to a second IMD. In order to improve the chances of a successfully received transmission, the first IMD may transmit the instructions several times during a particular time frame, such as during a single heartbeat. If the second IMD receives the message more than once, the second IMD recognizes that the messages were redundant and acts accordingly.Type: GrantFiled: October 29, 2020Date of Patent: February 28, 2023Assignee: CARDIAC PACEMAKERS, INC.Inventors: Brendan Early Koop, Paul Huelskamp, Lance Eric Juffer, Kyle Leonard Nelson, Keith R. Maile, Jacob M. Ludwig
-
Patent number: 11559235Abstract: In an example, an apparatus is described that includes an implantable housing, a heart signal sensing circuit configured to sense intrinsic electrical heart signals, a ventricular tachyarrhythmia (VT) detector circuit, operatively coupled to the heart signal sensing circuit, the detector circuit operable to detect a VT based on the sensed heart signals, a processor configured to control delivery of an anti-tachyarrhythmia pacing (ATP) therapy based on the detected VT, and an energy delivery circuit configured to deliver the ATP therapy in response to the detected VT, wherein the apparatus does not include a shock circuit capable of delivering a therapeutically-effective cardioverting or defibrillating shock.Type: GrantFiled: July 3, 2019Date of Patent: January 24, 2023Assignee: Cardiac Pacemakers, Inc.Inventor: Jacob M. Ludwig
-
Patent number: 11476927Abstract: Systems and methods for managing communication strategies between implanted medical devices. Methods include temporal optimization relative to one or more identified conditions in the body. A selected characteristic, such as a signal representative or linked to a biological function, is assessed to determine its likely impact on communication capabilities, and one or more communication strategies may be developed to optimize intra-body communication.Type: GrantFiled: July 12, 2018Date of Patent: October 18, 2022Assignee: CARDIAC PACEMAKERS, INC.Inventors: Jacob M. Ludwig, Michael J. Kane, Brendan E. Koop, William J. Linder, Keith R. Maile, Jeffrey E. Stahmann
-
Patent number: 11338135Abstract: Embodiments herein relate to medical device systems including electric field shaping elements for use in treating cancerous tumors within a bodily tissue. In an embodiment, a medical device system for treating a cancerous tumor is described. The medical device system can include one or more electric field generating electrodes and an electric field shaping element configured to be implanted along with the one or more electric field generating electrodes. The electric field shaping element can be made from a material that alters the spatial area of tissue exposed to the electric field. Other embodiments are also included herein.Type: GrantFiled: October 22, 2018Date of Patent: May 24, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Brian L. Schmidt, Jacob M. Ludwig, Benjamin J. Haasl, Michael J. Kane
-
Patent number: 11253710Abstract: This document discusses, among other things, systems and methods to fabricate and operate an implantable medical device. The implantable medical device can include a housing portion defining an interior chamber. The implantable medical device can include a circuit in the interior chamber. The implantable medical device can include a first electronic component that is not in the interior chamber. The implantable medical device can include a substrate coupled to the housing, the substrate including a first via extending through the substrate, the first via electrically coupling the first electronic component to the circuit.Type: GrantFiled: January 5, 2018Date of Patent: February 22, 2022Assignee: Cardiac Pacemakers, Inc.Inventors: Ron A. Balczewski, James E. Blood, William J. Linder, Jacob M. Ludwig, Keith R. Maile
-
Patent number: 11224751Abstract: Systems and methods for treating arrhythmias are disclosed. In one embodiment an LCP comprises a housing, a plurality of electrodes for sensing electrical signals emanating from outside of the housing, an energy storage module disposed within the housing, and a control module disposed within the housing and operatively coupled to the plurality of electrodes. The control module may be configured to receive electrical signals via two or more of the plurality of electrodes and determine if the received electrical signals are indicative of a command for the LCP to deliver ATP therapy. If the received electrical signals are indicative of a command for the LCP to deliver ATP therapy, the control module may additionally determine whether a triggered ATP therapy mode of the LCP is enabled. If the triggered ATP therapy mode is enabled, the control module may cause the LCP to deliver ATP therapy via the plurality of electrodes.Type: GrantFiled: January 31, 2019Date of Patent: January 18, 2022Assignee: CARDIAC PACEMAKERS, INC.Inventors: Paul Huelskamp, Jacob M. Ludwig, Lance E. Juffer, Keith R. Maile
-
Patent number: 10946202Abstract: Methods and devices for testing and configuring implantable medical device systems. A first medical device and a second medical device communicate with one another using test signals configured to provide data related to the quality of the communication signal to facilitate optimization of the communication approach. Some methods may be performed during surgery to implant one of the medical devices to ensure adequate communication availability.Type: GrantFiled: January 14, 2019Date of Patent: March 16, 2021Assignee: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, Brendan E. Koop, Brian L. Schmidt, Michael J. Kane, Jacob M. Ludwig, Jeffrey E. Stahmann, Lance E. Juffer
-
Publication number: 20210038904Abstract: Implantable medical devices (IMD), such as but not limited to leadless cardiac pacemakers (LCP), subcutaneous implantable cardioverter defibrillators (SICD), transvenous implantable cardioverter defibrillators, neuro-stimulators (NS), implantable monitors (IM), may be configured to communicate with each other. In some cases, a first IMD may transmit instructions to a second IMD. In order to improve the chances of a successfully received transmission, the first IMD may transmit the instructions several times during a particular time frame, such as during a single heartbeat. If the second IMD receives the message more than once, the second IMD recognizes that the messages were redundant and acts accordingly.Type: ApplicationFiled: October 29, 2020Publication date: February 11, 2021Applicant: CARDIAC PACEMAKERS, INC.Inventors: Brendan Early Koop, Paul Huelskamp, Lance Eric Juffer, Kyle Leonard Nelson, Keith R. Maile, Jacob M. Ludwig
-
Patent number: 10881869Abstract: Near-field energy transmitters for charging a rechargeable power source of an implantable medical device (IMD). In some cases, the transmitter may include an output driver that may drive a transmit coil such that near-field energy is transmitted to the IMD at a determined frequency. In some cases, the IMD may include a receiving coil that may capture the near-field energy and then convert the near-field energy into electrical energy that may be used to recharge the rechargeable power source. Since the rechargeable power source does not have to maintain sufficient energy stores in a single charge for the entire expected life of the IMD, the power source itself and thus the IMD may be made smaller while still meeting device longevity requirements.Type: GrantFiled: November 14, 2017Date of Patent: January 5, 2021Assignee: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, William J. Linder, Michael J. Kane, Jeffrey E. Stahmann, Jacob M. Ludwig, Brendan Early Koop, Daniel Joseph Landherr, Greg Paul Carpenter
-
Patent number: 10881863Abstract: Implantable medical devices such as leadless cardiac pacemakers may be configured to communicate using more than one mode of communication. For example, in some cases, an implantable medical device may be configured to communicate via conducted communication in some circumstances and to communicate via inductive communication in other circumstances. In some cases, the implantable medical device may be configured to switch between communication modes in order to improve communication.Type: GrantFiled: November 20, 2017Date of Patent: January 5, 2021Assignee: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, William J. Linder, Jacob M. Ludwig
-
Patent number: 10835753Abstract: Implantable medical devices (IMD), such as but not limited to leadless cardiac pacemakers (LCP), subcutaneous implantable cardioverter defibrillators (SICD), transvenous implantable cardioverter defibrillators, neuro-stimulators (NS), implantable monitors (IM), may be configured to communicate with each other. In some cases, a first IMD may transmit instructions to a second IMD. In order to improve the chances of a successfully received transmission, the first IMD may transmit the instructions several times during a particular time frame, such as during a single heartbeat. If the second IMD receives the message more than once, the second IMD recognizes that the messages were redundant and acts accordingly.Type: GrantFiled: January 25, 2018Date of Patent: November 17, 2020Assignee: CARDIAC PACEMAKERS, INC.Inventors: Brendan Early Koop, Paul Huelskamp, Lance Eric Juffer, Kyle Leonard Nelson, Keith R. Maile, Jacob M. Ludwig
-
Publication number: 20200338344Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system is included having at least one electric field generating circuit configured to generate one or more electric fields; control circuitry in communication with the electric field generating circuit, the control circuitry configured to control delivery of the one or more electric fields from the at least one electric field generating circuit; and two or more electrodes to deliver the electric fields to the site of a cancerous tumor within a patient. At least one electrode can be configured to be implanted. At least one electrode can be configured to be external. The control circuitry can cause the electric field generating circuit to generate one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz.Type: ApplicationFiled: April 22, 2020Publication date: October 29, 2020Inventors: Brian L. Schmidt, Devon N. Arnholt, Benjamin Keith Stein, Keith R. Maile, William J. Linder, Ron A. Balczewski, Jacob M. Ludwig, Aleksandra Kharam
-
Patent number: 10695572Abstract: A system for recharging an implantable medical device having a rechargeable battery while the implantable medical device is implanted within a patient includes a recharge energy source configured to be disposed exterior to the patient and a recharging bridge configured to be implanted within the patient. The recharging bridge is configured to facilitate energy transfer from the recharge energy source to the implantable medical device.Type: GrantFiled: March 29, 2018Date of Patent: June 30, 2020Assignee: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, Jacob M. Ludwig, William J. Linder
-
Patent number: 10639486Abstract: Implantable medical device (IMD) such as leadless cardiac pacemakers may include a rechargeable power source. In some cases, the IMD may include a plurality of receiving coils that may capture a non-radiative near-field energy and then convert the near-field energy into electrical energy that may be used to recharge the rechargeable power source. Accordingly, since the rechargeable power source does not have to maintain sufficient energy stores in a single charge for the entire expected life of the IMD, the power source itself and thus the IMD, may be made smaller while still meeting device longevity expectations.Type: GrantFiled: November 14, 2017Date of Patent: May 5, 2020Assignee: CARDIAC PACEMAKERS, INC.Inventors: William J. Linder, Michael J. Kane, Jeffrey E. Stahmann, Jacob M. Ludwig, Brendan Early Koop, Daniel Joseph Landherr, Greg Paul Carpenter, Keith R. Maile
-
Patent number: 10493290Abstract: A medical system for providing a defibrillation therapy to a patient includes a cardiac monitoring device (CMD) configured to sense and record physiological data indicative of the patient's cardiac function. The CMD includes a communication component. The system also includes an external therapy device configured to deliver defibrillation therapy, and configured to be positioned external to and supported by the patient. The external therapy device includes an external therapy device communication component. The CMD communication component and the external therapy device communication component are configured to operatively couple the CMD and the external therapy device to one another, so as to work as a system to detect and treat fibrillation.Type: GrantFiled: September 30, 2016Date of Patent: December 3, 2019Assignee: Cardiac Pacemakers, Inc.Inventors: Jacob M. Ludwig, Ron A. Balczewski, Todd W. Grotbeck, Keith R. Maile, Moira B. Sweeney
-
Publication number: 20190321649Abstract: In an example, an apparatus is described that includes an implantable housing, a heart signal sensing circuit configured to sense intrinsic electrical heart signals, a ventricular tachyarrhythmia (VT) detector circuit, operatively coupled to the heart signal sensing circuit, the detector circuit operable to detect a VT based on the sensed heart signals, a processor configured to control delivery of an anti-tachyarrhythmia pacing (ATP) therapy based on the detected VT, and an energy delivery circuit configured to deliver the ATP therapy in response to the detected VT, wherein the apparatus does not include a shock circuit capable of delivering a therapeutically-effective cardioverting or defibrillating shock.Type: ApplicationFiled: July 3, 2019Publication date: October 24, 2019Inventor: Jacob M. Ludwig
-
Patent number: 10434314Abstract: A medical system may include a first medical device such as a leadless cardiac pacemaker (LCP) that is configured to pace a patient's heart and a second medical device that is configured to have a capture threshold capability. The second medical device may monitor the patient's heart to ascertain whether the pacing pulses from the first medical device are capturing the heart, and to send the first medical device instructions to alter an energy level of subsequent pacing pulses.Type: GrantFiled: October 25, 2017Date of Patent: October 8, 2019Assignee: CARDIAC PACEMAKERS, INC.Inventors: Jacob M. Ludwig, Keith R. Maile
-
Patent number: 10413743Abstract: In an example, an apparatus is described that includes an implantable housing, a heart signal sensing circuit configured to sense intrinsic electrical heart signals, a ventricular tachyarrhythmia (VT) detector circuit, operatively coupled to the heart signal sensing circuit, the detector circuit operable to detect a VT based on the sensed heart signals, a processor configured to control delivery of an anti-tachyarrhythmia pacing (ATP) therapy based on the detected VT, and an energy delivery circuit configured to deliver the ATP therapy in response to the detected VT, wherein the apparatus does not include a shock circuit capable of delivering a therapeutically-effective cardioverting or defibrillating shock.Type: GrantFiled: October 9, 2017Date of Patent: September 17, 2019Assignee: Cardiac Pacemakers, Inc.Inventor: Jacob M. Ludwig